What's the evidence that NICE guidance has been implemented?: Maybe NICE needs to do more to ensure implementation of guidelinesBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7499.1085 (Published 05 May 2005) Cite this as: BMJ 2005;330:1085
- Rishi Mannan, intercalated BSc student in primary health care,
- Melvyn Jones, lecturer in general practice
- Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London
EDITOR—Sheldon et al investigated whether guidance from the National Institute for Clinical Excellence (NICE) has been implemented.1 We found a lack of implementation of newer guidance.
We examined how NICE guidance, published in August 2003, altered prescription rates of glitazones for type 2 diabetes mellitus. NICE recommended that glitazones be used as a second line treatment in combination with either metformin …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial